Comportamiento de la Retinopatía de la Prematuridad en la Provincia Artemisa (página 2)

Partes: 1, 2

32. Gilbert C, Fielder A, Gordillo L, Quinn G,
Semiglia R, Visintin P, et al. Characteristics of infants
with severe retinopathy of prematurity in countries with low,
moderate, and high levels of development. Implications for
screening programs. Pediatrics. 2005; 115: e518.

33. Gilbert C. New issues in childhood
blindness. Community EyeHealth. 2004; 9:1-7.

34. Tufail A, Singh AJ, Haynes RJ, et al. Late
onset vitreoretinal complications of regressed retinopathy of
Prematurity. Br J Ophthalmol. 2004; 88:243-246.

35. Dra. Paola Dorta S., Kychenthal A.
Retinopatía del premature. Taller de ROP, Perú.
2006.

36. Dr. Fuentes Hidalgo J., Dra. Mier M.
Proyecto para el apoyo a la prevención a la ceguera.
Cuba. Taller nacional de ROP. 2005.

37. Dr. Rodríguez Guilbeaux J. Dra Pons
Castro L. Hospital 10 de Octubre. Proyecto para el apoyo a la
prevención a la ceguera. Cuba. Taller nacional de ROP.
2005.

38. Dra.Mier M. Taller regional Cuba-Este ROP.
Hospital América Arias.2005.

39. Ells AL, MacKeen LD. Retinopathy of
prematurity-the movies. J AAPOS. 2004, 8: 389.

40. Dra. Montes E., Mier M., Proyecto para el
apoyo a la prevención a la ceguera. Cuba. Taller
Nacional de ROP, Hospital Eusebio Hernández.
2005.

41. Todd D. A, Wright A, Smith J, Group TN.
Severe retinopathy of prematurity in infants<30weeks"
gestation in New South Wales (NSW) and the Australian Capital
Territory (ACT) from 1992-2002. Arch Dis Child Fetal
Neonatal. 2007 Jan 24

42. Vander Veen D. K, Mansfield T. A,
Eichenwald E. C. Lower oxygen saturation alarm limits
decrease the severity of retinopathy of prematurity. J AAPOS.
2006;10: 445-8.

43. Schulenburg WE, Tsanaktsidis G. variations
in the morphology of retinopathy of prematurity in extremely
low birthweight infants. Br J Ophthalmol. 2004;88:
1500-3.

44. Wallace D. K, Veness-Meehan K. A, Miller
W. C. Incidence of severe retinopathy of prematurity before
and after a modest reduction in target oxygen saturation
levels. J AAPOS. 2007; 11:170-4.

45. Moro M, Figueras J, Fernández C,
Doménech E, Guzmán J, Jiménez R, et al,
y Grupo SEN 1500. Análisis de resultados de los datos
de morbimortalidad del grupo SEN 1500. Informes anuales
2002-2005. Disponible en:

http://www.se-neonatal.es/default_principal.asp?idx=&cidioma=2

(Agosto 2008).

46. Gunn TR, Eastdown J, Outerbridge EW,
Aranda JV. Risk factors in retrolental fibroplasia.
Pediatrics 1980; 65:1096-1100.
47. Kennedy J, Todd DA, Watts J, John E.
Retinopathy of prematurity in infants less than 29
week´s gestation: 3.5 years pre and post-surfactant. J
Pediatr Ophthalmology Strabismus 1997; 34:289-92.
48. Dani C, Reali MF, Bertini G, Martelli E,
Pezzati M, Rubaltelli FF. The role of blood transfusions and
iron intake on retinopathy of prematurity. Early Hum Dev
2001;62:57-63.
49. Leduc M, Kermorvant-Duchemin E, Checcin D,
Sennlaub F, Sirinyan M, Kooli A, et al. Hypercapmia and
trans-arachidonic acid-induced retinal microvascular
degeneration: Implications in the genesis of retinopathy of
prematurity. Semin Perinatol. 2006; 30:129-38.
50. Cordelia Colea, Alistair Fielderb, Edmund
Schulenburga Western Eye Hospital, Marylebone
Road London, UKCurrent Paediatrics Abril 2005
: 15, 99-105
51. Quinn GE, editor. What do we do about ROP
in larger birth weight babies? (Editorial). Br J Ophthalmol
2002;86: 1072-3.
52. Haines L, Fielder AR, Scrivener R, et al.
Retinopathy of prematurity in the UK 1: The organisation of
services for screening and treatment. Eye 2002;
16:33-8.
53. Early Treatment for Retinopathy of
Prematurity Cooperative Group (ET-ROP). Revised indications
for the treatment of retinopathy of prematurity. Arch
Ophthalmol 2003;121: 1684-96.
54. Schulenburg WE, Tsanakinsidis G. The
morphology in extreme prematurity. Br J Ophthalmol
2004;88(12):1500-3.
55. Moro M, Figueras J, Fernández C,
Doménech E, Guzmán J, Jiménez R, et al,
y Grupo SEN 1500. Análisis de resultados de los datos
de morbimortalidad del grupo SEN 1500. Informes anuales
2002-2005. Disponible en: http://www.se-neonatal.es/
default_principal.asp?idx = &cidioma = 2.
56. Todd DA, Wright A, Smith J, Group TN.
Severe retinopathy of prematurity in infants < 30 weeks'
gestation in New South Wales (NSW) and the Australian Capital
Territory (ACT) from 1992-2002. Arch Dis Child Fetal
Neonatal. 2007 Jan 24 (Epub ahead of print).
57. Terry TL. Extreme prematurity and
fibroblastic overgrowth of persistent vascular sheat behind
each crystalline lens. Preliminary report. Am J Ophthalmol.
1942;25:203-4.
58. Campbell K. Intensive oxygen therapy as a
possible cause of retrolental fibroplasia. A clinical
approach. Med J Aust. 1951; 2: 48. [Medline]
59. Tin W, Milligan DW, Pennefather P, Hey E.
Pulse oximetry, severe retinopathy, and outcome at one year
in babies of less than 28 weeks gestation. Arch Dis Child
Fetal Neonatal. 2000; 84: F106-10.
60. Chow LC, Wright KW, Sola A, CSMC oxygen
administration study group. Can changes in clinical practice
decrease the incidence of severe retinopathy of prematurity
in very low birth weight infants? Pediatrics. 2003; 111:
339-45.
61. Sola A, Chow L, Rogido M.
Retinopatías de la prematuridad y oxigenoterapia: una
relación cambiante. An Pediatr (Barc). 2005; 62:
48-63. [Medline]
62. Vander Veen DK, Mansfield TA, Eichenwald
EC. Lower oxygen saturation alarm limits decrease the
severity of retinopathy of prematurity. J AAPOS. 2006; 10:
445-8. [Medline]
63. Wallace DK, Veness-Meehan KA, Miller WC.
Incidence of severe retinopathy of prematurity before and
after a modest reduction in target oxygen saturation levels.
J AAPOS. 2007; 11: 170-4. [Medline]